lyophil_margin

TL3 Regular · Klaipėda, LT

Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.

Joined 26 September 2024 · last posted 2d · groups: analytical-chemists

138 posts, newest first. Showing up to 150.

Deletion sequences: expected mass shifts by residue — the long version Replied, post #24 · Analytics › Impurities & related substances · 26 Jul 2026 · 6 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
CJC-1295 with and without DAC: what the modification does Replied, post #121 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 1 like Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #42 · Clinical › Prescriber conversations · 24 Jul 2026 · 12 likes post #41 is right about the mechanism and I think understates the practical bit. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
Request: a per-category review queue Replied, post #125 · Meta › Feature requests · 23 Jul 2026 · 4 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #120 · Outcomes › Body composition · 23 Jul 2026 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #90 · Nutrition & Training › Protein & intake · 21 Jul 2026 · 13 likes This follows post #87 rather than contradicting it. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as…
Which categories are strict and which are relaxed, honestly Replied, post #22 · Start Here › Welcome · 17 Jul 2026 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Seven-day rolling means and why weekly readings mislead Replied, post #44 · Outcomes › Progress reports · 16 Jul 2026 · 11 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
How shortages have affected compounding permissions Replied, post #44 · Access › Shortages · 16 Jul 2026 · 15 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #31 · Compounds › Semaglutide · 15 Jul 2026 · 18 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #29 · Analytics › HPLC & UHPLC · 11 Jul 2026 · 20 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: How compounding permissions changed when supply normalised Replied, post #10 · Sourcing › Regulatory · 11 Jul 2026 · 2 likes post #9 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
MS/MS sequence confirmation: what it costs and when it is worth it Replied, post #5 · Analytics › Mass spectrometry · 8 Jul 2026 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #89 · Evidence › Journal club · 8 Jul 2026 · 21 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #77 · Meta › Announcements · 5 Jul 2026 · 33 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #33 · Compounds › Secretagogues & GH axis · 29 Jun 2026 · 24 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #24 · Practice › Dosing & titration · 29 Jun 2026 · 11 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
Primary endpoint hierarchies and why order matters — one year on Replied, post #29 · Evidence › Trials · 29 Jun 2026 · 2 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
How shortages have affected compounding permissions Replied, post #2 · Access › Shortages · 27 Jun 2026 · 5 likes the opening post answers the question as asked. The question underneath it is different. Patient advocacy during shortages: some advocacy groups advocate for patients…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #45 · Compounds › Secretagogues & GH axis · 22 Jun 2026 · 0 likes Picking up post #42: that is the part I would want checked first. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #60 · Start Here › How to Ask · 21 Jun 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #14 · Analytics › Impurities & related substances · 21 Jun 2026 · 0 likes On post #10 — agreed on the reasoning, with one qualification. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #68 · Meta › Announcements · 21 Jun 2026 · 27 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #46 · Evidence › Journal club · 20 Jun 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #113 · Practice › Reconstitution · 17 Jun 2026 · 5 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #80 · Data & Tools › Datasets · 14 Jun 2026 · 7 likes post #79 answers the question as asked. The question underneath it is different. Bias toward positive outcomes: datasets collected by members are biased toward people…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #29 · Analytics › HPLC & UHPLC · 13 Jun 2026 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
What to include when your question involves a chromatogram — one year on Replied, post #32 · Start Here › How to Ask · 10 Jun 2026 · 1 like Picking up post #29: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #52 · Wellbeing › Sleep · 6 Jun 2026 · 12 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #88 · Outcomes › Body composition · 3 Jun 2026 · 7 likes On post #84 — agreed on the reasoning, with one qualification. Maintenance phase: tracking body composition during maintenance (weight stable) is different from…
Official shortage notices and what they authorise Replied, post #76 · Access › Shortages · 29 May 2026 · 2 likes post #75 answers the question as asked. The question underneath it is different. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
Follow-up: Sleep quality changes during weight loss Replied, post #28 · Wellbeing › Sleep · 23 May 2026 · 1 like Coming back to post #26, because the follow-up matters more than the original answer. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #29 · Analytics › Method validation · 22 May 2026 · 8 likes post #28 is right about the mechanism and I think understates the practical bit. Stability-indicating method: one that can separate a compound from its degradation…
Bariatric surgery history: altered anatomy, altered expectations Replied, post #19 · Clinical › Special populations · 22 May 2026 · 1 like Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
Packaging that arrived damaged: documenting it properly Replied, post #12 · Sourcing › Logistics · 20 May 2026 · 4 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #24 · Compounds › Retatrutide · 17 May 2026 · 11 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #49 · Practice › Reconstitution · 12 May 2026 · 3 likes post #48 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
EU-wide position versus national implementation — what changed since Replied, post #26 · Regional › European Union · 9 May 2026 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
GLP-1 receptor distribution: central and peripheral Replied, post #45 · Pharmacology › Receptor biology · 7 May 2026 · 0 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #14 · Compounds › Tirzepatide · 1 May 2026 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal…
Follow-up: Reconciling a label claim with a content assay Replied, post #15 · Analytics › COA interpretation · 16 Apr 2026 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #12 · Compounds › Repair & healing peptides · 15 Apr 2026 · 31 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
Five questions in one post gets you one answer — how to split them Replied, post #48 · Start Here › How to Ask · 6 Apr 2026 · 22 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
Follow-up: State-level differences that actually matter Replied, post #8 · Regional › North America · 4 Apr 2026 · 27 likes post #7 is right about the mechanism and I think understates the practical bit. Provincial formularies in Canada are published and are the correct source for coverage…
Amylin receptor signalling and satiety — what changed since Replied, post #54 · Pharmacology › Receptor biology · 1 Apr 2026 · 2 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #40 · Practice › Storage & stability · 29 Mar 2026 · 8 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #29 · Outcomes › Body composition · 28 Mar 2026 · 12 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #80 · Research Methods › N-of-1 designs · 19 Mar 2026 · 23 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
Revisiting: Absolute versus relative contraindications Replied, post #44 · Safety › Contraindications · 15 Mar 2026 · 25 likes Picking up post #41: that is the part I would want checked first. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #63 · Lounge › Introductions · 14 Mar 2026 · 10 likes Ongoing: you can post multiple introductions over time. If you return after a long break, reintroducing yourself is fine.
A payment that went through twice: how it was resolved Replied, post #19 · Sourcing › Payments · 1 Mar 2026 · 5 likes post #18 is right about the mechanism and I think understates the practical bit. Bank transfer and finality: once a bank transfer is sent, it is final. The money is…
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #9 · Evidence › Journal club · 26 Feb 2026 · 1 like Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
The most useful thing you learned here that was not the answer you came for Replied, post #23 · Lounge › Off topic · 25 Feb 2026 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Guidelines revision: what changed and why — one year on Replied, post #72 · Meta › Announcements · 18 Feb 2026 · 0 likes This follows post #69 rather than contradicting it. Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #14 · Outcomes › Body composition · 8 Feb 2026 · 21 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #23 · Practice › Administration · 6 Feb 2026 · 0 likes Worth separating two things that post #19 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #12 · Analytics › COA interpretation · 19 Jan 2026 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #53 · Pharmacology › Pharmacokinetics · 5 Jan 2026 · 1 like post #52 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #53 · Access › Pricing · 4 Jan 2026 · 1 like This follows post #50 rather than contradicting it. Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #125 · Documentation › Doc review · 3 Jan 2026 · 16 likes On post #121 — agreed on the reasoning, with one qualification. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page,…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #78 · Compounds › Semaglutide · 26 Dec 2025 · 0 likes I read post #76 twice before replying, because I had assumed the opposite. The mass figure differs between sources because of how the different entities report it. The…
Selection into a registry and what it does to the estimate Replied, post #2 · Evidence › Study critique · 22 Dec 2025 · 18 likes This follows the opening post rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #4 · Evidence › Journal club · 22 Dec 2025 · 0 likes Worth separating two things that post #2 runs together. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #65 · Compounds › Tirzepatide · 9 Dec 2025 · 7 likes post #64 answers the question as asked. The question underneath it is different. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide,…
Documentation that appears only after payment Replied, post #98 · Sourcing › Red flags · 6 Dec 2025 · 0 likes I read post #96 twice before replying, because I had assumed the opposite. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or…
Reading SURMOUNT-1 without the press release — one year on Replied, post #26 · Compounds › Tirzepatide · 1 Dec 2025 · 29 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Second pass at: The topic list is dense — is that deliberate? Replied, post #10 · Meta › Site feedback · 29 Nov 2025 · 7 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #13 · Analytics › Impurities & related substances · 15 Nov 2025 · 0 likes Worth separating two things that post #9 runs together. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in…
[2026 update] What steady state means for the decision to escalate Replied, post #58 · Practice › Dosing & titration · 11 Nov 2025 · 16 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #47 · Practice › Interactions · 10 Nov 2025 · 15 likes This follows post #44 rather than contradicting it. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #15 · Research Methods › N-of-1 designs · 29 Oct 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
New subcategory: rationale and scope Replied, post #40 · Meta › Announcements · 16 Oct 2025 · 23 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
Documentation that materially improves an appeal's chances Replied, post #29 · Access › Insurance & coverage · 15 Oct 2025 · 3 likes Coming back to post #27, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #10 · Evidence › Journal club · 10 Oct 2025 · 1 like Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Sleep quality changes during weight loss — what changed since Replied, post #18 · Wellbeing › Sleep · 6 Oct 2025 · 24 likes Coming back to post #16, because the follow-up matters more than the original answer. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic…
Which panel is worth repeating and which is worth ignoring Replied, post #121 · Clinical › Bloodwork · 26 Sep 2025 · 4 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
Payment method and the leverage it gives you, ranked Replied, post #60 · Sourcing › Payments · 23 Sep 2025 · 6 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
Insurance and replacement policies, compared — the long version Replied, post #15 · Sourcing › Logistics · 13 Sep 2025 · 4 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #88 · Data & Tools › Datasets · 9 Sep 2025 · 11 likes Picking up post #85: that is the part I would want checked first. Privacy: if contributing data, only share data you are comfortable making permanent and public. Once…
What this community means by "a source", in practical terms Replied, post #100 · Start Here › Welcome · 5 Sep 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Aggregated purity results across four services, with caveats Replied, post #3 · Data & Tools › Datasets · 3 Sep 2025 · 2 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #5 · Practice › Side effects · 22 Aug 2025 · 4 likes This follows post #2 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Coming back to: What published stability data actually covers, and what it does not Replied, post #118 · Practice › Storage & stability · 20 Aug 2025 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
Gauge and length selection for subcutaneous injection Replied, post #20 · Devices › Syringes & needles · 13 Aug 2025 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
A request that was declined, and the reasoning — a second dataset Replied, post #76 · Documentation › Wiki requests · 13 Aug 2025 · 25 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #33 · Sourcing › Regulatory · 24 Jun 2025 · 3 likes Worth separating two things that post #29 runs together. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with…
Sodium, potassium and magnesium when intake drops Replied, post #21 · Nutrition & Training › Hydration & electrolytes · 18 Jun 2025 · 3 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #28 · Evidence › Trials · 12 Jun 2025 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
[2026 update] An appeal that failed, and what I would do differently Replied, post #41 · Access › Insurance & coverage · 9 Jun 2025 · 30 likes post #40 answers the question as asked. The question underneath it is different. Documentation your clinician can provide: letters from clinicians describing why…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #104 · Clinical › Comorbidities · 4 Jun 2025 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #125 · Compounds › Semaglutide · 19 May 2025 · 2 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Ipamorelin selectivity claims and where they came from Replied, post #34 · Compounds › Secretagogues & GH axis · 3 May 2025 · 33 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #15 · Evidence › Journal club · 3 May 2025 · 25 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #24 · Evidence › Journal club · 30 Apr 2025 · 12 likes On post #20 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #5 · Evidence › Journal club · 29 Apr 2025 · 4 likes post #4 answers the question as asked. The question underneath it is different. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
UK access routes, dated and sourced — a second dataset Replied, post #68 · Regional › UK & Ireland · 24 Apr 2025 · 1 like MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #127 · Evidence › Journal club · 23 Apr 2025 · 30 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Counter-ion content and its effect on measured mass Replied, post #22 · Analytics › Mass spectrometry · 21 Apr 2025 · 4 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
The C-cell question: rodent findings and their human context Replied, post #9 · Compounds › Semaglutide · 19 Apr 2025 · 1 like Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
A well-designed study with a badly written abstract Replied, post #24 · Evidence › Study critique · 14 Apr 2025 · 5 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
Follow-up: Open-label extensions: what survives and what does not Replied, post #25 · Evidence › Trials · 3 Apr 2025 · 16 likes Coming back to post #23, because the follow-up matters more than the original answer. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #18 · Access › Pricing · 27 Mar 2025 · 0 likes On post #14 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #107 · Sourcing › Regulatory · 17 Mar 2025 · 0 likes I read post #105 twice before replying, because I had assumed the opposite. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical…
Reading an MS report that only gives you a single number Replied, post #26 · Analytics › Mass spectrometry · 10 Mar 2025 · 15 likes On post #22 — agreed on the reasoning, with one qualification. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #48 · Sourcing › Regulatory · 1 Mar 2025 · 25 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #17 · Sourcing › Regulatory · 27 Feb 2025 · 5 likes post #16 answers the question as asked. The question underneath it is different. Primary documents matter: regulatory positions are published in official documents.…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #15 · Compounds › Secretagogues & GH axis · 24 Feb 2025 · 0 likes I read post #13 twice before replying, because I had assumed the opposite. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #57 · Pharmacology › Receptor biology · 20 Feb 2025 · 2 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #48 · Pharmacology › Receptor biology · 11 Feb 2025 · 0 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
Consistent declarations and why they matter more than clever ones Replied, post #4 · Sourcing › Logistics · 6 Feb 2025 · 0 likes post #3 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
SURPASS-2 and the comparator dose question that will not go away Replied, post #105 · Compounds › Tirzepatide · 15 Jan 2025 · 10 likes This follows post #102 rather than contradicting it. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that…
Recovery when intake is low: what to cut first Replied, post #54 · Nutrition & Training › Resistance training · 13 Jan 2025 · 30 likes Coming back to post #52, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Scheduled maintenance and what will be unavailable Replied, post #12 · Meta › Announcements · 10 Jan 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Recovery when intake is low: what to cut first Replied, post #18 · Nutrition & Training › Resistance training · 10 Jan 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A promotion I argued against, and why I lost Replied, post #48 · Documentation › Doc review · 2 Jan 2025 · 21 likes Coming back to post #46, because the follow-up matters more than the original answer. Review of promoted topics: when a topic is nominated for promotion to a maintained…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #43 · Practice › Interactions · 31 Dec 2024 · 23 likes This follows post #40 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Body image changing more slowly than the body Replied, post #54 · Wellbeing › Mental health · 17 Dec 2024 · 6 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #62 · Access › Insurance & coverage · 9 Dec 2024 · 24 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #53 · Access › Insurance & coverage · 3 Dec 2024 · 14 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #7 · Data & Tools › Calculators · 30 Nov 2024 · 29 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
Coming back to: When to suspect the method rather than the sample Replied, post #7 · marked as the solution · Analytics › Method validation · 28 Nov 2024 · 15 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
Injection-site reactions: describing them precisely enough to be useful Replied, post #30 · Practice › Side effects · 27 Nov 2024 · 7 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #32 · Compounds › Semaglutide · 18 Nov 2024 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Follow-up: Escalating every six weeks instead of four: what I observed over eight months Replied, post #3 · Practice › Dosing & titration · 17 Nov 2024 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
EMA product information as a primary source — does this still hold? Replied, post #54 · Regional › European Union · 16 Nov 2024 · 0 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
Glucagon receptor agonism in a weight-loss compound Replied, post #2 · Pharmacology › Receptor biology · 3 Nov 2024 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Bias and desensitisation: receptors can be biased (preferentially activating some…
Micronutrient status when intake falls substantially — a second dataset Replied, post #4 · Clinical › Bloodwork · 30 Oct 2024 · 2 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
Promotion criteria, and the one that stops most nominations Replied, post #97 · Documentation › Doc review · 27 Oct 2024 · 23 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #59 · Compounds › Other compounds · 19 Oct 2024 · 0 likes I read post #57 twice before replying, because I had assumed the opposite. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
Why a preprint's supplementary material is often the best part Replied, post #27 · Evidence › Preprints · 17 Sep 2024 · 25 likes Coming back to post #25, because the follow-up matters more than the original answer. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #60 · Sourcing › Independent verification · 15 Sep 2024 · 9 likes Picking up post #57: that is the part I would want checked first. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two…
Chronic kidney disease and the FLOW result Replied, post #29 · Clinical › Comorbidities · 20 Aug 2024 · 16 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
Correlation in a self-tracked dataset: what it can support Replied, post #3 · Research Methods › Statistics · 19 Aug 2024 · 23 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
Identical chromatograms across two different lots Replied, post #16 · Sourcing › Red flags · 19 Aug 2024 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Patterns that reliably precede a problem: underdosing (less active material than stated, documented by…
Blind submission and why it changes minds Replied, post #31 · Sourcing › Independent verification · 7 Aug 2024 · 24 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #9 · Evidence › Journal club · 3 Aug 2024 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #8 · Safety › Contraindications · 15 Jul 2024 · 0 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
The mass-error checker and its intended scope Replied, post #58 · Data & Tools › Calculators · 18 Jun 2024 · 21 likes I read post #56 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…